QHSLab, Inc. operates as a medical device technology and software as a service company. The company is headquartered in West Palm Beach, Florida and currently employs 4 full-time employees. The company went IPO on 2002-01-09. Its Quality Health System Lab Expert System (QHSLab), a digital healthcare platform, provides clinical decision support and point of care solutions and supports non-face-to-face remote patient and therapeutic monitoring, to address chronic care and preventive medicine and is reimbursable to medical practice. The company also markets and sells point-of-care, rapid-response diagnostic tests used in primary care practice. QHSLab offers a variety of digital healthcare intervention programs including allergies and asthma, mental health, musculoskeletal health and pain, hypertension, sleep disorders, weight loss and much more. The firm sells allergy diagnostic-related products and immunotherapy treatments to physicians.
El segmento de ingresos más grande es QHSLab Inc, con unos ingresos de Allergy Diagnostic Kit en el último informe de ganancias. En cuanto a la geografía, United States es el mercado principal para QHSLab Inc, con unos ingresos de 1,408,995.